Dec. 4 at 9:05 PM
$RFL Okay, if Jonas & Co. had good data back in June of 2025, why would they sit on it? In order to arrive at the most amazing outcome ever at 96-weeks? Were that the case, would not the trial have been easily concluded early for the benefit of the children and the 96-week data tracked by the company regardless?
Jonas has stated mid-2026 for 96-week data and won’t have an escape hatch available this time. I’m thinking April for a re-entry. I expect a PR emphasizing all manner of NDA considerations other than a stat-sig result in July or August.
Let’s see what happens.
